Search results
Results from the Health.Zone Content Network
Ubuntu Single Sign On (also known as Ubuntu SSO, Launchpad Login Service) is an OpenID-based single sign-on service provided by Canonical to allow users to log into many websites. On June 21, 2013, Canonical announced that Ubuntu Single Sign On would be re-branded under Ubuntu One as part of consolidating Canonical's online services under the ...
During its early years, Launchpad LA operated as a networking group without an official office space or equity requirements. Instead, it focused on organizing regular events and dinners to support the participating companies. By 2011, Launchpad LA had accepted 23 companies into its mentorship program, with an impressive 19 of them receiving ...
Launchpad is an application launcher that was first introduced in OS X Lion. It displays all applications installed on the user's machine in a grid of icons, which can be put into folders. Launchpad provides an alternative way to start applications in macOS, in addition to other options such as the Dock, Finder, and Spotlight search.
Use an app password. If you use AOL two-step verification or an older email app, you may need to use an app specific password to access AOL Mail. Learn how to generate third-party app passwords and remember, app passwords are only valid for the app they are created for and remain valid until you sign out or remove access to the app. At that ...
increased shortness of breath. swelling in the ankles, legs, abdomen, or other parts of your body. fatigue. chest discomfort. sudden weight gain. reduced exercise tolerance. persistent cough or ...
Symptoms include chest pain, shortness of breath, and a dry cough. It can be caused by problems like heart failure, blood clots, pneumonia, kidney disease, and tuberculosis. Pneumonia. Pneumonia ...
InterSign ASL. InterSign ASL is a relatively new visual-only app with more than 90 lessons. It offers a dictionary, glossary, and games. The developers are planning to include sign variants ...
Eversense CGM. Eversense, a subcutaneous implant device made by Senseonics, is another type of CGM on the market. It was FDA approved in 2019 for people with diabetes. Eversense works via a small ...